Is Butterfly Medical’s prostate retraction device the next challenger in minimally invasive BPH treatment?
BPH care needs options beyond pills and surgery. Butterfly Medical’s $21m raise puts its reversible prostate implant in the spotlight.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Can ProVee change how BPH is treated? FDA nod gives ProVerum its biggest win yet
ProVerum wins FDA approval for ProVee, a permanent urethral stent for BPH offering fast recovery and no catheter. See how it could disrupt the urology device market.